The goal of this prospective non-randomised study is to test the feasibility of leadless conduction system pacing using the WiSE-CRT device in patients with an indication for Cardiac Resynchronisation Therapy. The main question\[s\] it aims to answer are: 1. What is the safety profile of leadless conduction system pacing? 2. What is the success rate of leadless conduction system pacing? 3. What are the electrical and haemodynamic effects of leadless conduction system pacing. Participants will undergo pre-procedural cardiac CT, and post-procedure electro-anatomical mapping and haemodynamic assessments.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
15
Participants undergo pre-procedural CT, implantation of the WiSE-CRT system targeting the left bundle branch area, and post procedural non-invasive electro-anatomical mapping using electrocardiographic imaging and haemodynamic assessment.
Procedure/Device related complication rate
Number of procedure or device related complications
Time frame: 6 months
Success rate
Percentage of successful tracking
Time frame: 6 months
LV function
Percentage of patients with a 15% reduction in LV end systolic volume
Time frame: 6 months
Clinical outcome
Percentage of patients with improvement in NYHA class
Time frame: 6 months
ECG outcome
Mean change in QRS duration
Time frame: 6 months
Biventricular activation time
Mean change in biventricular activation time
Time frame: 6 weeks
Haemodynamic improvement
Mean change in acute haemodynamic dP/dT
Time frame: 6 weeks
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.